Relation of Antiphospholipid Antibodies to Postmortem Brain Infarcts in Older PeopleCLINICAL PERSPECTIVE by Zoe Arvanitakis, Robin L. Brey, Jacob H. Rand,

Slides:



Advertisements
Similar presentations
Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome by Jacob H. Rand,
Advertisements

SORVEGLIANZA DELLE MALATTIE NEOPLASTICHE. Cancer statistics, 2013 CA: A Cancer Journal for Clinicians Volume 63, Issue 1, pages 11-30, 17 JAN 2013 DOI:
Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.
Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Antiphospholipid Antibodies and Subsequent Thrombo-occlusive.
Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus ErythematosusClinical Perspective by.
Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2): July 10, 2012 Copyright.
Early Outcomes of Tricuspid Valve Replacement in Young Children by Heather L. Bartlett, Dianne L. Atkins, Trudy L. Burns, Kelly J. Engelkes, Sarah J. Powell,
Bariatric Surgery and Cardiovascular Risk Factors by Paul Poirier, Marc-André Cornier, Theodore Mazzone, Sasha Stiles, Susan Cummings, Samuel Klein, Peter.
Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):
Guide to the Assessment of Physical Activity: Clinical and Research Applications by Scott J. Strath, Leonard A. Kaminsky, Barbara E. Ainsworth, Ulf Ekelund,
Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction by Mikhail Kosiborod, Saif S. Rathore, Silvio E. Inzucchi,
The Global Cardiovascular Risk TransitionClinical Perspective by Goodarz Danaei, Gitanjali M. Singh, Christopher J. Paciorek, John K. Lin, Melanie J. Cowan,
Can Adenosine 5′-Triphosphate Be Used to Select Treatment in Severe Vasovagal Syndrome? by Daniel Flammang, Timothy Church, Marc Waynberger, Annick Chassing,
Endogenous Marinobufagenin-like Immunoreactive Factor and Na +,K + ATPase Inhibition During Voluntary Hypoventilation by Alexei Y. Bagrov, Olga V. Fedorova,
Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After.
by Michael D. Elliott, Ajoy Kapoor, Michele A. Parker, Dixon B
Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States by Brahmajee K. Nallamothu, Eric R. Bates, Yongfei.
Copyright © 2004 American Medical Association. All rights reserved.
Circ Cardiovasc Qual Outcomes
by Adam J. Singer, Robert H
Comparison of Triflusal and Aspirin for Prevention of Vascular Events in Patients After Cerebral Infarction by Jordi Matías-Guiu, José M. Ferro, José Alvarez-Sabín,
Circ Cardiovasc Interv
by Adolfo Correa, Sophia Greer, and Mario Sims
Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,
by Yehuda G. Wolf, Christopher K. Zarins, Geoffrey D
B-Type Natriuretic Peptide Testing and the Accuracy of Heart Failure Diagnosis in the Emergency DepartmentCLINICAL PERSPECTIVE by Amaali Lokuge, Louisa.
Decrease in Intra-Abdominal Visceral Fat May Reduce Blood Pressure in Obese Hypertensive Women by Hideyuki Kanai, Katsuto Tokunaga, Shigenori Fujioka,
Atrial Fibrillation and Mortality in Heart FailureClinical Perspective
by William H. Sauer, Concepcion Alonso, Erica Zado, Joshua M
Left Ventricular Longitudinal Function Predicts Life-Threatening Ventricular Arrhythmia and Death in Adults With Repaired Tetralogy of FallotClinical Perspective.
by Jennifer L. Dearborn, Andrea L. C. Schneider, A
by Salim Yusuf, and Sonia Anand
Plasma Vitamin C, but Not Vitamin E, Is Associated With Reduced Risk of Heart Failure in Older MenClinical Perspective by Sasiwarang Goya Wannamethee,
Noninfectious Mitral Annular Disruption
Risk of Recurrent Stroke in Patients With Silent Brain Infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) Imaging Substudy.
Association Between Mycoplasma Pneumonia and Increased Risk of Ischemic Stroke by Chia-Hung Chiang, Chin-Chou Huang, Wan-Leong Chan, Yu-Chun Chen, Tzeng-Ji.
Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.
UnTEThering (Smooth Muscle) Cell Plasticity
Behavior and Biology: The Basic Sciences for AHA Action
Physician and Patient Influences on Provider Performance
by Thomas Monks, Martin Pitt, Ken Stein, and Martin James
Relative Distributions
Left Ventricular Assist Device Outflow Cannula Obstruction Treated With Percutaneous Endovascular Stenting by Jacob Abraham, Joshua D. Remick, Todd Caulfield,
Influence of Cardiac Surgeon Report Cards on Patient Referral by Cardiologists in New York State After 20 Years of Public Reporting by David L. Brown,
Contribution of Stroke to the Cochrane Stroke Group Trials Register
New Frontiers in Cardiology
Circ Cardiovasc Imaging
Virtual Reality in Stroke Rehabilitation
Silent Brain Infarcts by Yi-Cheng Zhu, Carole Dufouil, Christophe Tzourio, and Hugues Chabriat Stroke Volume 42(4): March 28, 2011 Copyright ©
by Beverly G. Windham, Michael E
Effect of intervention on diastolic function.
Randomized Clinical Trial of Therapeutic Exercise in Subacute Stroke
by Amy Kuceyeski, Hooman Kamel, Babak B
by Clarisse Toledo, George Thomas, Jesse D
Body Mass Index and Heart Failure Among Patients With Type 2 Diabetes MellitusCLINICAL PERSPECTIVE by Weiqin Li, Peter T. Katzmarzyk, Ronald Horswell,
Resting Ventricular–Vascular Function and Exercise Capacity in Heart Failure With Preserved Ejection FractionCLINICAL PERSPECTIVE by Selma F. Mohammed,
Cardiovascular Risk Factors and Sequelae in Hypertensive Children Identified by Referral Versus School-Based Screening by Jonathan M. Sorof, Jennifer Turner,
The Process of Rehabilitation and Discharge Planning in Stroke
Pulse Pressure and Resistance Artery Structure in the Elderly
by Alexander Leaf, Christine M
by Cheryl D. Bushnell, and Larry B. Goldstein
Risk of Recurrent Cardiac Events After Onset of Menopause in Women With Congenital Long-QT Syndrome Types 1 and 2Clinical Perspective by Jonathan Buber,
POINT: Will New Anti-eosinophilic Drugs Be Useful in Asthma Management
Copyright © 2014, 2000, 1992 Elsevier Inc. All rights reserved.
Conventional treatment to prevent obstetric complications during pregnancy. *Antiphospholipid (aPL) antibody carriers: individuals with aPL positivity.
Figure 2 Kaplan-Meier survival graphs for 10-year risks of overall and post-90-day recurrent ischemic stroke (IS) and death Kaplan-Meier survival graphs.
Association of MRI findings and serum autoantibodies in diffuse neuropsychiatric systemic lupus erythematosus. Association of MRI findings and serum autoantibodies.
Antibody levels to Ro52, Ro60, p200 and La antigens in control and congenital heart block (CHB) cohort were measured as bound units (BU). Antibody levels.
Jenna Barton, MSN, RN-C, PCCN
Presentation transcript:

Relation of Antiphospholipid Antibodies to Postmortem Brain Infarcts in Older PeopleCLINICAL PERSPECTIVE by Zoe Arvanitakis, Robin L. Brey, Jacob H. Rand, Julie A. Schneider, Ana W. Capuano, Lei Yu, Sue E. Leurgans, David A. Bennett, and Steven R. Levine Circulation Volume 131(2): January 13, 2015 Copyright © American Heart Association, Inc. All rights reserved.

Number of subjects with overall antiphospholipid antibodies (aPLs) at baseline by overall aPLs proximate to death. Zoe Arvanitakis et al. Circulation. 2015;131: Copyright © American Heart Association, Inc. All rights reserved.

Proportion of subjects with antiphospholipid antibodies (aPLs) at baseline (BL) by aPLs proximate to death. aCL indicates anticardiolipin; anti-β2GPI, anti–β2-glycoprotein I; aPS, anti- phosphatidyl-serine antibodies; and LA, lupus anticoagulant. Zoe Arvanitakis et al. Circulation. 2015;131: Copyright © American Heart Association, Inc. All rights reserved.